SpaceX looks to raise $1.7 billion in new funding, boosting its valuation to $127 billion

SpaceX looks to raise .7 billion in new funding, boosting its valuation to 7 billion


A Falcon 9 rocket launches a batch of Starlink satellites to orbit on April 29, 2022.

SpaceX

SpaceX is raising a massive round of fresh funding, CNBC has learned, sending the private company’s valuation to about $127 billion.

The space venture is looking to bring in up to $1.725 billion in new capital, at a price of $70 per share, according to a company-wide email on Friday obtained by CNBC. Notably, SpaceX split its stock price 10-for-1 in February, which reduced the common stock to $56 a share – with the new valuation representing a 25% increase.

SpaceX is also conducting a secondary sale to company insiders and existing shareholders for up to $750 million in common stock. The company conducts these secondary offerings regularly, as a way for long-time stockholders to sell equity, given that SpaceX remains private more than 20 years since its founding.

Details of the cash infusion were not previously reported. The New York Post first reported SpaceX was looking to bring in more funding, and noted, citing unnamed sources, that the capital increase has seen “tepid demand” so far.

The company’s valuation has soared in the last few years as SpaceX has raised billions to fund work on two capital-intensive projects: the next generation rocket Starship and its global satellite internet network Starlink.

The company’s funding round comes as founder and CEO Elon Musk is embroiled in sexual harassment allegations reportedly from a former SpaceX jet flight attendant. The billionaire has denied the claims made against him as “wild accusations.” The flight attendant reportedly did not sue SpaceX, and instead reached a $250,000 severance agreement in 2018.



Source

Lilly to spend up to .8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Business

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said Tuesday. Centessa is one of several companies working […]

Read More
‘Project Hail Mary’ is the box office proof point Amazon MGM has been waiting for
Business

‘Project Hail Mary’ is the box office proof point Amazon MGM has been waiting for

“Project Hail Mary” is setting records for Amazon MGM and lighting the path for a box-office revitalization. The science fiction flick, starring Ryan Gosling, has tallied more than $300 million globally since its theatrical opening two weeks ago. That marks the best performance for an Amazon MGM film ever. “The runaway success of ‘Project Hail […]

Read More
McCormick buys Unilever’s food business in deal that values it at nearly  billion
Business

McCormick buys Unilever’s food business in deal that values it at nearly $45 billion

Jars of Unilever brand Hellmann’s mayonnaise for sale at a store in Dobbs Ferry, New York, U.S., Wednesday, Jan. 19, 2022. Tiffany Hagler-Geard | Bloomberg | Getty Images McCormick will buy Unilever’s food business for a combination of cash and equity, in a deal that values the Unilever unit at nearly $45 billion, the two […]

Read More